Brind.

Quest Diagnostics raises 2026 guidance; plans Epic deployment

1 report, 1 independent Updated Thu 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Quest Diagnostics reported third-quarter revenue of $3.10 billion and raised its full-year 2026 guidance. The company also announced plans to deploy Epic solutions in 2027 and offered tailored tests to US iPhone users.

From dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The company reported strong organic revenue growth and increased operating income in the third quarter. The raised full-year guidance and the planned integration of Epic solutions signal continued financial strength and strategic technological investment in the healthcare sector.

From dailypolitical.com

Who's involved

  • Quest DiagnosticsReported third-quarter revenue and raised full-year guidance
  • EpicProvider of solutions Quest Diagnostics plans to deploy in 2027
  • New York Stock ExchangeVenue where Quest Diagnostics held its investor day
  • Apple Inc.Platform through which Quest Diagnostics offers tailored tests

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • EpicSpeculative

    Epic could see increased revenue from the planned deployment of its solutions by Quest Diagnostics.

  • Apple Inc.Speculative

    Apple Inc. might see increased user demand for Quest Diagnostics' tailored tests through its health platform.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped